Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Takeda Pharmaceutical will eliminate an unspecified number of jobs as part of an R&D revamp. The company says it plans to centralize research in the U.S. and Japan, suggesting that its R&D center in the U.K., which employs 400, is threatened. Takeda’s research center in Shonan, Japan, on which it recently spent $1.8 billion, will concentrate on the central nervous system and regenerative medicine. The company also will continue to research vaccines, gastroenterology, and oncology. The layoffs and related restructuring will cost $740 million over the next two years, the firm anticipates.
This article has been sent to the following recipient: